Novartis is a Swiss pharmaceutical company that researches, develops, and sells medicines globally across multiple therapeutic areas including cardiovascular, immunology, oncology, and hematology. Its portfolio includes treatments for conditions such as heart failure, cancer, autoimmune disorders, blood disorders, and rare genetic diseases, with notable drugs like Entresto for heart failure, Cosentyx for inflammatory diseases, and Kisqali for certain cancers. The company also operates through partnerships, including a collaboration with Alnylam Pharmaceuticals to commercialize a cholesterol-reducing therapy.
1Y: 138.70 (+16.9%) · range 118.20–163.64
entry readiness 62 · MODERATE · exit proximity 0
Value area 146.34–157.88 · 95% of 120d volume overhead · heavy supply
| Source | Score | Last seen |
|---|---|---|
| forum-chatter | 0.384 | Sep 8, 2026 |
| trend-signal | 0.005 | Sep 3, 2026 |
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +4.72% | +4.72% | mature |
| 40d | -10.40% | +6.54% | 36/40d |